
Selected publications from PubMed
Pharmacometric Targets During Anti-TNF Induction and Their Association with Deep Remission in Pediatric Crohn's Disease.
Nasr A, Mizuno T, Irie K, Dillman JR, Jackson K, Lynch K, Horrell A, Aviles T, Chun K, Yang J, Boyle B, Hyams JS, Noe J, Denson LA, Minar P
Clin Pharmacokinet. 2026 Sep;65(9):1353-1365 doi: 10.1007/s40262-026-01685-7.
Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.
Bartel C, Mizuno T, Karns R, Irie K, Jackson K, Lynch K, Samuels A, Hyams JS, Boyle B, Kurowski JA, Saeed S, Noe JD, Chun K, Yang J, Denson LA, Minar P
Crohns Colitis 360. 2026 Jul;8(3):otag088 doi: 10.1093/crocol/otag088.
Elevated circulating lactate in late-stage melanoma patients.
Rendon BE, Yan J, Li H, Noe JT, Deng Z, Hall M, Kong M, Chesney JA, Mitchell RA
QJM. 2026 Jul 8 pii: hcag179. doi: 10.1093/qjmed/hcag179.
Leukocytoclastic vasculitis and necrobiotic pulmonary nodules in endoscopic remission of ulcerative colitis.
Noe JD, Bistolarides J, Wanat KA, Chiu Y
JPGN Rep. 2026 May;7(2):309-311 doi: 10.1002/jpr3.70158.
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.
Irie K, Minar P, Reifenberg J, Boyle BM, Noe JD, Hyams JS, Mizuno T
Clin Pharmacol Ther. 2026 Feb;119(2):555-563 doi: 10.1002/cpt.70118.
Help your network discover Dr. Jaimie Noe's clinical expertise.